Innophos Holdings Inc, founded in 2004 and headquartered in Cranbury, New Jersey, specializes in the development and manufacturing of specialty phosphates for various industries. The company plays a crucial role in enhancing food, beverage, and pharmaceutical products through its diverse portfolio of nutritional ingredients and performance materials.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| IPHS 11.50% 2029-06-15 USDInnophos Holdings Inc | United States | 2029-06-15 | 11.500 | 18.48 |
| IPHS 9.38% 2028-02-15 USDInnophos Holdings Inc | United States | 2028-02-15 | 9.375 | 9.84 |
| IPHS 9.38% 2028-02-15 USDInnophos Holdings Inc | United States | 2028-02-15 | 9.375 | 9.84 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Innophos has a history of bond issuances dating back to its early years, with notable offerings including a $150 million senior secured note in 2017, aimed at refinancing debt obligations to improve its capital structure. Current yields on Innophos bonds are competitive within the specialty chemicals sector, reflecting the company's strong financial health and strategic initiatives. Recent news highlights the successful completion of a bond offering in early 2023, aimed at funding expansion projects, and features such as call options that provide added flexibility for investors.